Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Am J Kidney Dis. 2010 Nov 30;57(1):78–89. doi: 10.1053/j.ajkd.2010.08.028

Table 6.

Mean Changes in US Prevalent CVC and AVF Use, January 2007 – April 2010

Vascular Access January 2007 (%) April 2010 (%) Difference (95% CI) P-value
CVC
    ≥ 90 days 12.0 9.5 -2.5 (-2.7, -2.2) < 0.001
    < 90 days 6.8 5.4 -1.4 (-1.6, -1.2) < 0.001
    with AVF 7.9 7.5 -0.4 (-0.6, -0.2) < 0.001
    with AVG 2.1 1.7 -0.5 (-0.6, -0.4) < 0.001
    Total 28.8 24.0 -4.7 (-5.0, -4.4) < 0.001
AVF 45.3 55.5 10.2 (9.8, 10.5) < 0.001

Source: Centers for Medicare & Medicaid Services, Vascular Access Data Set as delivered by the Network Information Technology Support contractor to Fistula First Breakthrough Initiative contractor, January 2007 – April 2010.

Arterio-venous Fistula (AVF); AVG, arteriovenous graft; Central Venous Catheter (CVC)